Impaired muscle mitochondrial energetics is associated with uremic metabolite accumulation in chronic kidney disease
Chronic kidney disease (CKD) causes progressive skeletal myopathy involving atrophy, weakness, and fatigue. Mitochondria have been thought to contribute to skeletal myopathy; however, the molecular mechanisms underlying muscle metabolism changes in CKD are unknown. We employed a comprehensive mitoch...
Main Authors: | Trace Thome, Ravi A. Kumar, Sarah K. Burke, Ram B. Khattri, Zachary R. Salyers, Rachel C. Kelley, Madeline D. Coleman, Demetra D. Christou, Russell T. Hepple, Salvatore T. Scali, Leonardo F. Ferreira, Terence E. Ryan |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2021-01-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.139826 |
Similar Items
-
An AMPK activator as a therapeutic option for congenital nephrogenic diabetes insipidus
by: Janet D. Klein, et al.
Published: (2021-04-01) -
Developing nephrology services in low income countries: a case of Tanzania
by: Francis F. Furia, et al.
Published: (2019-10-01) -
Selective inhibition of arginase-2 in endothelial cells but not proximal tubules reduces renal fibrosis
by: Michael D. Wetzel, et al.
Published: (2020-10-01) -
Chronic kidney disease in HIV populations: prevalence, risk factors and role of transforming growth factor beta (TGF-߀1) polymorphisms
by: Ekrikpo, Udeme Ekpenyong
Published: (2020) -
Patient outcomes in a PD First Program in Cape Town, South Africa
by: Davidson, Bianca
Published: (2018)